Form 4: Cigna Group Chairman & CEO David Cordani Executes Stock Option and Sells Shares Under 10b5-1 Plan
SEC Form 4 Filing
David Cordani, Chairman & CEO of Cigna Group, exercised stock options and sold shares of common stock between February 23 and February 27, 2024, under a pre-arranged Rule 10b5-1 trading plan.
Summary
- David Cordani, the Chairman & CEO of Cigna Group, engaged in transactions involving the company's common stock between February 23 and February 27, 2024.
- These transactions included the exercise of employee stock options and the subsequent sale of shares.
- The exercises were related to options with an exercise price of $139.22.
- The sales were executed at prices ranging from approximately $345.00 to $347.14 per share.
- These transactions were conducted under a pre-arranged Rule 10b5-1 trading plan adopted on May 15, 2023.
- Cordani also holds shares indirectly through a 401(k) plan (1,727.2938 shares), a GRAT (99,918 shares), and a trust (153,801 shares).
Sentiment
Score: 5
Explanation: The document is a routine regulatory filing detailing stock transactions by a company executive. It doesn't inherently convey positive or negative sentiment.
Industry Context
Executive stock transactions are a common occurrence in publicly traded companies. The use of Rule 10b5-1 plans allows insiders to sell shares over a period of time without being accused of trading on non-public information.
Comparison to Industry Standards
- Executive compensation packages often include stock options as a form of long-term incentive.
- The vesting schedules and exercise prices of these options are typically benchmarked against industry peers.
- The use of 10b5-1 trading plans is a standard practice among corporate executives to manage their personal finances and diversify their holdings.
Stakeholder Impact
- The transactions may have a minor impact on shareholders due to the change in ownership.
- The transactions do not appear to have a direct impact on employees, customers, suppliers, or creditors.
Key Dates
| Date | Description |
|---|---|
| 03/01/2016 | Date employee stock option was granted. |
| 03/01/2017 | First vesting date of the employee stock option. |
| 05/15/2023 | Date the Rule 10b5-1 trading plan was adopted. |
| 02/23/2024 | Date of first transaction: exercise of options and sale of shares. |
| 02/26/2024 | Date of second transaction: exercise of options and sale of shares. |
| 02/27/2024 | Date of third transaction: exercise of options and sale of shares. |
| 03/01/2026 | Expiration date of the employee stock option. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.